brilique 90 new

Brilique 90 mg contains Ticagrelor, a potent antiplatelet medication belonging to the P2Y12 receptor antagonist class. It is primarily prescribed to prevent serious cardiovascular events, such as heart attacks and strokes, in patients with acute coronary syndrome or a history of myocardial infarction. By inhibiting platelet aggregation, it helps maintain blood flow through the arteries and prevents the formation of harmful blood clots. This medication is a critical component of long-term cardiovascular management and must be taken strictly as directed by a cardiologist to ensure therapeutic efficacy and patient safety.